The effect of secondary prophylaxisversusepisodic treatment on the range of motion of target joints in patients with haemophilia-Reference-Cited by-同舟云学术

The effect of secondary prophylaxisversusepisodic treatment on the range of motion of target joints in patients with haemophilia

Published:2013-02-22 Issue:3 Volume:161 Page:424-433
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Gupta Sweta¹,Siddiqi Azfar-E-Alam²,Soucie J. Michael²,Manco-Johnson Marilyn³,Kulkarni Roshni⁴,Lane Heidi⁵,Ingram-Rich Robina⁶,Gill Joan C.⁷,

Affiliation:

1. Indiana Hemophilia and Thrombosis Center; Indianapolis; IN; USA

2. Division of Blood Disorders; National Center on Birth Defects and Developmental Disabilities; Centers for Disease Control and Prevention; Atlanta; GA; USA

3. University of Colorado; Denver; CO; USA

4. Michigan State University; East Lansing; MI; USA

5. Intermountain Hemophilia and Thrombosis Center, Primary Children's Medical Center; Salt Lake City; UT; USA

6. Oregon Hemophilia Center, CDRC/Doernbecher Children's Hospital, Oregon Health & Science University; Portland; OR; USA

7. Medical College of Wisconsin and the Comprehensive Centre for Bleeding Disorders, Blood Center of Wisconsin; Milwaukee; WI; USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12267/fullpdf

Reference35 articles.

1. Patterns of bleeding in adolescents with severe haemophilia A;Aronstam;British Medical Journal,1979

2. Modern treatment of haemophilia;Berntorp;Bulletin of the World Health Organization,1995

3. The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey;Biss;Haemophilia,2008

4. A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centres;Blanchette;Haemophilia,2003

5. Blood safety monitoring among persons with bleeding disorders - United States, May 1998-June 2002;Centers for Disease Control and Prevention (CDC);Morbidity and Mortality Weekly Report,2002

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment regimens, patient reported outcomes and health-related quality of life in children with moderate and severe hemophilia A in China: using real-world data;Orphanet Journal of Rare Diseases;2023-08-04

2. Assessment of joint bleeding and target joints in patients with severe or moderately severe hemophilia B (factor IX ≤2%) receiving prophylaxis with rIX‐FP in the PROLONG‐9FP clinical trial program;European Journal of Haematology;2023-05-26

3. Treatment regimens, patient reported outcomes and health-related quality of life in children with moderate and severe haemophilia A in China: using real-world data;2023-04-20

4. Effectiveness of Prophylactic Coagulation Factor Replacement Therapy in Patients with Severe Hemophilia A in Taiwan – A Population-Based Study;Clinical Epidemiology;2022-12

5. Exploration of the minimum necessary FVIII level at different physical activity levels in pediatric patients with hemophilia A;Frontiers in Pediatrics;2022-11-01